Clinical history
Oxandrolone has a documented medical history in specific clinical contexts. Those studies describe defined products and monitored populations; they should not be treated as validation of an unknown tablet sold under the same name.
Evidence needs its setting
Reported outcomes and laboratory changes depend on the studied dose, duration and population. A useful summary states those conditions and avoids extending them beyond the data.
Why product testing appears often
Oxandrolone-labelled products are frequently discussed in counterfeit and substitution reports. Tablet appearance cannot establish identity, so analytical findings should be attached to a named sample and batch where possible.